ESRRA and metabolic dysfunction-associated steatotic liver disease: Importantly, disturbance of ERRα expression in female mice contributes to NAFLD/NASH development in physiological conditions such as estrogen deficiency and pharmacological conditions such as tamoxifen treatment.